Translational Cancer Medicine

Course Overview

Pursue your ambitions in medicine and dentistry with the ResM (Research Masters) Translational Cancer Medicine at King's College London, University of London. Based in London, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time structure. Translational Cancer Medicine enables you to gain detailed knowledge and understanding of research methods applied to rational drug design, clinical study design, molecular and cell biology, tumour immunology, genetics and cancer imaging. You'll gain practical experience through two six-month laboratory rotations. * Key benefits* - A unique research course that includes the study of advanced imaging methods and tumour immunology. A minimum ielts score of 6.5 is required for admission. Graduates from this programme benefit from strong career prospects, with 92% student satisfaction rating, a 100% continuation rate, and 77% of graduates in employment or further study.

What You'll Learn

Tuition Fees & Funding

Home fee status: 25 August 2026 (23:59 UK time) If the programme becomes full before the final application deadlines stated above, we will close the programme to further applications.Please note, you will not be eligible for an application fee refund if we are unable to process further offers because places are filled and we close the course before the final application deadline. This course information applied to 2026 entry only. The University may make changes to a programme of study or module

Graduate Outcomes

Frequently Asked Questions